NCT02697877View on ClinicalTrials.gov

Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements

CompletedOBSERVATIONAL

Enrollment

183

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

July 31, 2018

Conditions

Coronary Artery Disease

Interventions

DRUG

Regadenoson

Trial Locations (1)

60612

1740 W Taylor Street, 2nd Floor, Cardiac Imaging, Chicago

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

University of Illinois at Chicago

OTHER

NCT02697877 - Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements | Biotech Hunter | Biotech Hunter